Clinical Trial Update: Study of Thymosin Beta 4 in Patients With Venous Stasis Ulcers [Phase 2]

View source ↗

Summary

Phase 2 trial of Thymosin Beta 4 in venous stasis ulcers has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Venous Stasis Ulcers

Drugs mentioned

• Thymosin beta-4 (thymosin beta-4)

Snippet

Sponsor: RegeneRx Biopharmaceuticals, Inc. | Conditions: Venous Stasis Ulcers | Phase 2 | Status: COMPLETED | Results posted: 2010-03-24